13F

Stock

Tg Therapeutics, Inc.

TGTX · held by 16 managers

Reported value

$96.5M

Holders

16

+3 new · −0 exited

Holders’ est. mark

$62K

Price effect on 3 books still in the name

Largest holder

$45.1M

MORGAN STANLEY

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
MORGAN STANLEY1.25M$45.1MHeld
BANK OF AMERICA CORP /DE/626.7K$22.6MHeld
BARCLAYS PLC458.2K$16.6M$61.9KCut−$5.78M
IFP Advisors, Inc196.9K$7.11MHeld
TUDOR INVESTMENT CORP ET AL76.1K$2.75MHeld
CANTOR FITZGERALD, L. P.32K$1.16MHeld
Persistent Asset Partners Ltd14K$507.2KHeld
Cresset Asset Management, LLC9.24K$333.7KNew
Swiss Life Asset Management Ltd6.94K$250.7KNew
Leonteq Securities AG2.88K$104.2K$180Added$56K
Noble Wealth Management PBC900$32.5KHeld
Allworth Financial LP567$20.5KHeld
Prestige Wealth Management Group LLC50$1.81K$7Added$7
Essential Partners LLC13$470New
KBC Group NV4.14K$150Held
FNY Investment Advisers, LLC409$14Held

Positions as of Q3 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.